Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 764

1.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
2.

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.

Carter NJ, Curran MP.

Drugs. 2011 Aug 20;71(12):1591-622. doi: 10.2165/11206860-000000000-00000. Review.

PMID:
21861544
3.
4.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

5.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

6.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
7.

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Ambrose CS, Luke C, Coelingh K.

Influenza Other Respir Viruses. 2008 Nov;2(6):193-202. doi: 10.1111/j.1750-2659.2008.00056.x. Review.

8.

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults.

Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00414-16. doi: 10.1128/CVI.00414-16. Print 2017 Jan.

9.

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.

J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23.

PMID:
21949042
10.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U.

GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

11.

Vaccines for preventing influenza in people with asthma.

Cates CJ, Rowe BH.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD000364. doi: 10.1002/14651858.CD000364.pub4. Review.

PMID:
23450529
12.

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.

Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X.

Vaccine. 2010 Feb 25;28(9):2149-56. doi: 10.1016/j.vaccine.2009.11.068. Epub 2009 Dec 8.

PMID:
20003926
13.

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.

Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2549-57. Epub 2012 Mar 14.

14.

Effectiveness and safety of influenza vaccination in children: European perspective.

Heikkinen T, Heinonen S.

Vaccine. 2011 Oct 6;29(43):7529-34. doi: 10.1016/j.vaccine.2011.08.011. Epub 2011 Aug 4. Review.

PMID:
21820481
15.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
16.

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.

Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.

PMID:
19095024
17.
18.

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.

PMID:
11740317
19.

Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.

[No authors listed]

Prescrire Int. 2013 Sep;22(141):201-4.

PMID:
24171209
20.

Influenza vaccines: present and future.

Subbarao K.

Adv Virus Res. 1999;54:349-73.

PMID:
10547679

Supplemental Content

Support Center